CGM Device Guide
MiniMed Instinct (made by Abbott)
Coming soon to the UK. The Instinct is a continuous glucose monitor designed by Abbott, made exclusively for MiniMed. Hardware profile matches Abbott FreeStyle Libre 3 Plus on size, accuracy, and the rest of the hardware bits (5/5 hardware); functionality matches MiniMed Simplera Sync (single-AID integration with the MiniMed 780G only, no optional calibration). It joined the MiniMed 780G sensor portfolio on 10 March 2026 (CE Mark), sitting alongside Guardian Sensor 4 (7-day) and Simplera Sync (7-day) as the 15-day option. US shipping began December 2025 after FDA approval. European commercial launch is expected in summer 2026; UK launch date to be confirmed.
Framework status (provisional)
Data sufficiency: Not yet met. CE Mark dossier and FDA submission exist but public-domain pivotal summary is pending.
Device at a glance
| Manufacturer | Abbott (designed and made exclusively for MiniMed AID) |
| Wear duration | Up to 15 days (per MiniMed 10 Mar 2026 press release; ADCES spec sheet lists 8 to 15 days) |
| Warm-up | Approximately 1 hour (per ADCES spec sheet; the shortest warm-up of the three 780G sensors) |
| Design | Single-piece, fully disposable sensor and transmitter. Described by MiniMed as “the world’s smallest, thinnest, most discreet CGM”. |
| Insertion | One-handed, dedicated applicator (per MiniMed 10 Mar 2026 press release) |
| Placement | Upper arm (expected per Abbott’s Libre family heritage and the announcement’s one-handed applicator description; formal labelling TBC) |
| Calibration | Factory calibrated, no fingersticks required (per ADCES spec sheet) |
| Smartphone app | MiniMed Mobile app required for sensor start; caregiver Follow function included (per ADCES spec sheet) |
| AID compatibility | MiniMed 780G only (Abbott-MiniMed exclusivity). Not interchangeable with FreeStyle Libre 3 or other Abbott consumer CGMs. Cannot be paired with Tandem, CamAPS FX, or Omnipod 5. |
| Age, sensor alone | CE and FDA non-adjunctive from age 2 (confirmed by MiniMed 22 Apr 2026). Not yet in Pemberton 2026 Table 1; a Table 1 addendum is expected. |
| Age, within 780G AID system | UK/EU (UKCA/CE): 2 years and older, T1D and insulin-requiring T2D with TDD ≥6 U/day; CE marked for pregnancy. US (FDA): T1D 7 years and older; insulin-requiring T2D 18 years and older; NOT approved for pregnancy. The SYSTEM age binds in the US (SmartGuard label), even though the Instinct sensor itself is FDA 2+. |
| US reimbursement | DME benefit and Pharmacy Benefit; Medicare full or partial coverage (per ADCES spec sheet) |
| UK reimbursement | TBC. UK launch date not confirmed as of 22 Apr 2026. |
| Variant products | Instinct Go – used in the MiniMed Go Smart MDI system (a separate product line, not AID). Same Abbott-MiniMed exclusivity. Europe launch summer 2026. |
[Image: MiniMed Instinct sensor (15-day, Abbott-made) and MiniMed 780G pump, awaiting editorial images from MiniMed and Abbott]
What distinguishes the Instinct in the MiniMed 780G portfolio
- 15-day wear versus 7-day for Guardian Sensor 4 and Simplera Sync. Roughly half the sensor changes per month, which is meaningful for cost, adhesion burden, and continuity of data.
- Smallest and thinnest integrated CGM available, per the MiniMed 10 Mar 2026 announcement. Described as roughly the size of two stacked pennies.
- Approximately 1-hour warm-up, the shortest of the three 780G-compatible sensors.
- Factory-calibrated, no fingersticks. Consistent with current-generation non-adjunctive CGM class devices; FDA interoperability (iCGM) classification unconfirmed as of 22 April 2026.
- One-handed insertion via a dedicated applicator. Reduces the procedural complexity of a sensor change.
- Designed exclusively for MiniMed AID. The Instinct sensor is not a FreeStyle Libre consumer variant and cannot be used with the FreeStyle LibreLink app, LibreView, or any non-MiniMed pump.
The MiniMed 780G three-sensor portfolio (as of 10 March 2026)
Before 10 March 2026, the MiniMed 780G supported one sensor route (Simplera Sync). From 10 March 2026 onwards, the 780G supports three sensors. All three sit inside the MiniMed ecosystem; the 780G remains not compatible with Dexcom or with the consumer FreeStyle Libre product line.
| Sensor | Manufacturer | Wear | Warm-up | Notes |
|---|---|---|---|---|
| Guardian Sensor 4 | MiniMed | 7 days | ~2 hours | CE non-adjunctive age 2+; FDA adjunctive only, age 7+ (per Pemberton 2026 Table 1). |
| MiniMed Simplera Sync | MiniMed | ~7 days (6 + 24 h grace) | ~2 hours | All-in-one disposable; CE and FDA non-adjunctive, age 2+. GNL page. |
| Instinct (this page) | Abbott (for MiniMed) | Up to 15 days | ~1 hour | Smallest and thinnest of the three; one-handed insertion; Abbott-MiniMed exclusive. |
Exclusivity, what Instinct is and is not
The Instinct sensor is manufactured by Abbott under an exclusive MiniMed integration agreement. It is not a FreeStyle Libre consumer variant.
- Instinct and FreeStyle Libre 3 or Libre 3 Plus are different products. They are not interchangeable.
- Instinct is not available over the counter. It is part of the MiniMed 780G AID prescription, or the MiniMed Go Smart MDI system (Instinct Go variant).
- Instinct does not work with the FreeStyle Libre app, LibreLink, LibreView, or any Abbott consumer smartphone app. It communicates with MiniMed devices and the MiniMed ecosystem.
- Anyone who is not on a MiniMed AID or Go system cannot use an Instinct sensor.
Who this is for
The Instinct sensor is relevant to patients on the MiniMed 780G AID system who want the longest sensor wear available in the MiniMed portfolio, and to patients considering the MiniMed Go Smart MDI system (with the Instinct Go variant) for multiple daily injection therapy with continuous monitoring.
The Instinct sensor is not a standalone CGM. Moving to Instinct from Dexcom G7 or the FreeStyle Libre 3 Plus means moving to the MiniMed 780G AID system (or the MiniMed Go MDI system) as well. The prescription and clinical decision are joint.
Availability and launch timeline
| United States | FDA approved. Shipping began December 2025 (per MiniMed / ADCES). |
| European Union (CE Mark) | CE Mark granted 10 March 2026 (MiniMed press release). Commercial launch in select European countries expected in summer 2026. |
| United Kingdom | Launch date TBC. As of 22 April 2026 no UK launch date is public. Expected to follow the European rollout but the MHRA/UKCA path is separate. |
| Other regions | Not specified in the 10 March 2026 press release. |
Page status, 22 April 2026
This page is provisional. CE Mark issued 10 March 2026 and US shipping began December 2025, but public-domain pivotal accuracy data is not yet available and the UK launch date has not been confirmed. We are updating the page in rolling fashion as data lands. Clear “TBD” flags appear on the framework score, agreement rates, sensor-level age, and UK launch rows. Once pivotal accuracy is published and the sensor appears in a regulatory summary such as Pemberton 2026 Table 1, this page will move to full CGM Guide framework inclusion.
Sources (current)
- MiniMed Group, Inc. “MiniMed expands sensor portfolio in Europe with CE Mark for MiniMed 780G system with the Instinct sensor, made by Abbott.” Press release, Northridge CA, 10 March 2026. Source of three-sensor portfolio claim, Instinct specifications (15-day wear, smallest/thinnest integrated CGM, no fingerstick calibration), and expanded European indications (T1 and insulin-requiring T2 from age 2, TDD ≥6 U/day, CE marked for pregnancy) versus US indications (T1 ≥7, T2 ≥18, no pregnancy).
- ADCES / danatech. Instinct sensor spec sheet (undated, cites US shipping start December 2025 after FDA approval). Confirms 8-15 days wear, approximately 1 hour warm-up, no required calibration, smartphone compatibility, caregiver Follow, DME and Pharmacy Benefit, Medicare full or partial coverage, paediatric use with adult supervision.
- Medtronic plc. “Medtronic announces MiniMed as name for planned New Diabetes Company.” Press release, Galway, 12 June 2025. Source for MiniMed rebrand. 780G US label “for type 1 ages 7 and over”.
- Pemberton JS, Moser O, Zaharieva DP, et al. Continuous glucose monitoring: an international clinical opinion on transparency, standardisation, and calibration alignment. Diabetes Obes Metab. 2026;28(4):2551-2565. doi:10.1111/dom.70460. Table 1 is the canonical reference for CGM regulatory ages. Instinct is not in Table 1 (cutoff predates CE Mark); update pending.
Page last updated 22 April 2026. Next update scheduled when pivotal accuracy data is published or when additional regulatory detail lands.